外资成港股IPO基石投资“大户” 青睐这些赛道

Group 1 - The enthusiasm of foreign institutions for cornerstone investments in Hong Kong IPOs has surged this year, with 15 out of 27 companies introducing foreign investors as cornerstone investors, compared to only 3 in the same period last year [1][3] - Cornerstone investors are typically large institutions, corporate groups, or well-known wealthy individuals who commit to purchasing a certain number of shares at the issue price before the IPO, with a lock-up period of 6 to 12 months [3] - Notable companies attracting foreign cornerstone investors include Ningde Times, which had one of the largest IPOs in recent years, introducing 23 cornerstone investors, including global sovereign wealth funds and multinational asset management giants [3][4] Group 2 - The new consumption and pharmaceutical sectors are particularly favored by foreign investors, with companies like Mixue Group and Biorun attracting significant investments and experiencing substantial stock price increases post-IPO [3][4] - In the pharmaceutical sector, companies like Yimeng Bio and Weisheng Pharmaceuticals have also drawn attention from foreign cornerstone investors, enhancing market confidence and long-term value through strategic collaborations [4] - The increase in foreign cornerstone investors in Hong Kong IPOs reflects a resonance between international capital allocation needs and China's industrial upgrade dividends, with a notable return of funds previously invested in dollar assets [4]